» Articles » PMID: 25693757

Chronic Pruritus in the Elderly: Pathophysiology, Diagnosis and Management

Overview
Journal Drugs Aging
Specialties Geriatrics
Pharmacology
Date 2015 Feb 20
PMID 25693757
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic itch in the elderly is a common problem, with a significant impact on quality of life and sleep in elderly patients. Chronic itch may be attributable to several causes, including dry skin, immunosenescence and neural degeneration. Itch may also be caused by skin diseases, such as seborrhoeic dermatitis and stasis dermatitis; systemic conditions, such as end-stage renal disease and diabetes; and psychogenic conditions, such as depression and anxiety. The use of polypharmacy may also cause itch, with or without a rash. Specifically, thiazides and calcium channel blockers have been known to cause itch in elderly patients. Management should be tailored according to the underlying dermatological or systemic aetiology of itch. Topical treatment is the mainstay of therapy, providing special emphasis on skin hydration and barrier repair. In addition, topical and oral medications that target the nervous system and reduce neuronal hypersensitization, such as gabapentin and selective antidepressants, have a role in treating patients with severe chronic itch. Furthermore, management must account for changes in metabolism and pharmacokinetics of drugs in the aging population in order to prevent the occurrence of adverse effects.

Citing Articles

Topical Medications for Chronic Itch in Older Patients: Navigating a Pressing Need.

Bartley B, Pierce C, Hivnor C, Valdes-Rodriguez R Drugs Aging. 2025; 42(3):213-233.

PMID: 39883297 DOI: 10.1007/s40266-024-01174-1.


Model of Chronic Itch in Aged Mice: Beneficial Effects of Drugs Affecting Descending Modulatory Systems.

Kojima G, Komiya E, Honda K, Kaneko T, Suga Y, Tominaga M Acta Derm Venereol. 2024; 104:adv39950.

PMID: 38751178 PMC: 11110811. DOI: 10.2340/actadv.v104.39950.


Immunosenescence and Skin: A State of Art of Its Etiopathogenetic Role and Crucial Watershed for Systemic Implications.

Papa V, Li Pomi F, Borgia F, Vaccaro M, Pioggia G, Gangemi S Int J Mol Sci. 2023; 24(9).

PMID: 37175661 PMC: 10178319. DOI: 10.3390/ijms24097956.


Retrospective Analysis of Dermatological Diseases in Geriatric Patients During Dermatology Outpatient Department Visits.

Sarac G, Emeksiz M, Acar O, Nazlican E, Tanacan E, Nayir T Dermatol Pract Concept. 2022; 12(3):e2022145.

PMID: 36159154 PMC: 9464519. DOI: 10.5826/dpc.1203a145.


Evaluation of the efficacy and safety of artemether emulsion on localized senile pruritus: A randomized pilot study.

He H, Shen W, Pei Q, Fei J, Yu Y, Qin H Medicine (Baltimore). 2022; 101(35):e30472.

PMID: 36107571 PMC: 9439745. DOI: 10.1097/MD.0000000000030472.


References
1.
Weisshaar E, Weiss M, Mettang T, Yosipovitch G, Zylicz Z . Paraneoplastic itch: an expert position statement from the Special Interest Group (SIG) of the International Forum on the Study of Itch (IFSI). Acta Derm Venereol. 2014; 95(3):261-5. DOI: 10.2340/00015555-1959. View

2.
Yosipovitch G . Dry skin and impairment of barrier function associated with itch - new insights. Int J Cosmet Sci. 2008; 26(1):1-7. DOI: 10.1111/j.0142-5463.2004.00199.x. View

3.
Thapa D, Jha A, Kharel C, Shrestha S . Dermatological problems in geriatric patients: a hospital based study. Nepal Med Coll J. 2013; 14(3):193-5. View

4.
Raison-Peyron N, Meunier L, Acevedo M, Meynadier J . Notalgia paresthetica: clinical, physiopathological and therapeutic aspects. A study of 12 cases. J Eur Acad Dermatol Venereol. 1999; 12(3):215-21. View

5.
Yosipovitch G, Bernhard J . Clinical practice. Chronic pruritus. N Engl J Med. 2013; 368(17):1625-34. DOI: 10.1056/NEJMcp1208814. View